Principal Scientist, Formulation Development
Sage Therapeutics
Cambridge, Massachusetts
Amy is a Principal Scientist in the Formulation Development group at Sage Therapeutics whose focus is develping novel molecules and mechanisms to treat a variety of brain health disorders. Before joining Sage she spent 7 years at Merck Research Laboratories in the Pharmaceutical Sciences organization. Amy's industrial experience ranges from physical chemical characterization, early clinical formulation development of oral and parenteral products, biopharmaceutics, and CMC leadership. Prior to joining the pharmaceutical industry, Amy received a B.S. in Pharmaceutical Sciences from the University at Buffalo (SUNY) and a PhD in Pharmaceutical Sciences from the University of Michigan.
Job Offers 101: What to Expect Across Different Career Stages
Monday, October 23, 2023
3:00 PM – 4:00 PM ET